Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
Author:
Affiliation:
1. The Miriam Hospital, Division of Hematology and Oncology, 164 Summit Ave, Fain Building, Providence, RI 02906, USA ; ;
2. Boston University School of Medicine, Roger Williams Medical Center, Department of Medicine, Providence, RI, USA
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/13543780902832679
Reference41 articles.
1. Lymphoma and the Control of B Cell Growth and Differentiation
2. B cells flying solo
3. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
4. The Risk of Lymphoma Development in Autoimmune Diseases
5. Cancer Statistics, 2008
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical efficacy of anti-CD20 antibodies in autoimmune diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024
2. A meaningful exploration of ofatumumab in refractory NMOSD: a case report;Frontiers in Immunology;2023-06-28
3. Immunotherapy for Pemphigus: Present and Future;Frontiers in Medicine;2022-06-15
4. Monoclonal Antibody-Based Treatment and Other New Agents for B-Lineage Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022
5. The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers;Cancers;2021-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3